New Deterrent Stimulants for ADHD

Video

What observations are being noted in the field with new agents for the treatment of ADHD?

Timothy Wilens, MD, talks about the presentation of the APSARD 2021 conference on ADAIR Pharmacokinetics and Pharmacodynamic Data. More on the presentation can be found here.

Dr Wilens is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital.

Related Videos
ADHD
ADHD
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
Related Content
What is new in research on opioid use disorder?

Opioid Use Disorder Research Roundup: April 19, 2024

April 19th 2024
Article
Treating ADHD in Children: Concerns, Controversies, Safety Measures

Treating ADHD in Children: Concerns, Controversies, Safety Measures

July 10th 2020
Podcast
“The heart of the matter.” Researchers investigated the risk of cardiovascular disease associated with long-term ADHD medication use.

ADHD Medications and Long-Term Cardiovascular Risk

March 29th 2024
Article
ADHD in Older Adults

ADHD in Older Adults

August 15th 2016
Podcast
What is new in research on child and adolescent psychiatry?

Child and Adolescent Psychiatry Research Roundup: March 15, 2024

March 15th 2024
Article
Here’s why ADHD is a diagnosis of exclusion.

Are We Over-Diagnosing ADHD Based on “Hyperactivity"?

March 14th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.